Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis
Background & Aims Ethanol-inducible cytochrome P450 2E1 (CYP2E1) activity contributes to oxidative stress. However, CYP2E1 may have an important role in the pathogenesis of high-fat mediated non-alcoholic steatohepatitis (NASH). Thus, the role of CYP2E1 in high-fat mediated NASH development was...
Gespeichert in:
Veröffentlicht in: | Journal of hepatology 2012-10, Vol.57 (4), p.860-866 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 866 |
---|---|
container_issue | 4 |
container_start_page | 860 |
container_title | Journal of hepatology |
container_volume | 57 |
creator | Abdelmegeed, Mohamed A Banerjee, Atrayee Yoo, Seong-Ho Jang, Sehwan Gonzalez, Frank J Song, Byoung-Joon |
description | Background & Aims Ethanol-inducible cytochrome P450 2E1 (CYP2E1) activity contributes to oxidative stress. However, CYP2E1 may have an important role in the pathogenesis of high-fat mediated non-alcoholic steatohepatitis (NASH). Thus, the role of CYP2E1 in high-fat mediated NASH development was evaluated. Methods Male wild type (WT) and Cyp2e1 -null mice were fed a low-fat diet (LFD, 10% energy-derived) or a high-fat diet (HFD, 60% energy-derived) for 10 weeks. Liver histology and tissue homogenates were examined for various parameters of oxidative stress and inflammation. Results Liver histology showed that only WT mice fed a HFD developed NASH despite the presence of increased steatosis in both WT and Cyp2e1 -null mice fed HFD. Markers of oxidative stress such as elevated CYP2E1 activity and protein amounts, lipid peroxidation, protein carbonylation, nitration, and glycation with increased phospho-JNK were all markedly elevated only in the livers of HFD-fed WT mice. Furthermore, while the levels of inflammation markers osteopontin and F4/80 were higher in HFD-fed WT mice, TNFα and MCP-1 levels were lower compared to the corresponding LFD-fed WT. Finally, only HFD-fed WT mice exhibited increased insulin resistance and impaired glucose tolerance. Conclusions These data suggest that CYP2E1 is critically important in NASH development by promoting oxidative/nitrosative stress, protein modifications, inflammation, and insulin resistance. |
doi_str_mv | 10.1016/j.jhep.2012.05.019 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1041143536</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168827812004199</els_id><sourcerecordid>1041143536</sourcerecordid><originalsourceid>FETCH-LOGICAL-c551t-baf70aa48004bde7f1f918b6446e1d1a3bcdc846367ea6cb36802a36d2794e2c3</originalsourceid><addsrcrecordid>eNp9kk2L1TAUhoMoznX0D7iQbIRx0Zqvpi2IIJfxAwYcUBeuQpqe2tQ2uZOkA_ffm3KvCi5cnc3znnN4zkHoOSUlJVS-nspphEPJCGUlqUpC2wdoRyUhBZGCPkS7DDVFw-rmAj2JcSKEcNKKx-iCMSkbydsdCvtgkzV6xsHPgP2AzTF5Mwa_AL4VFcHsmuKr_ffbXF9h63AaAfdwD7M_LODSFhntjxEPOhXW9auBHjvvCj0bP_rZGhwT6OTzqjrlWfEpejToOcKzc71E395ff91_LG4-f_i0f3dTmKqiqej0UBOtRUOI6HqoBzq0tOmkEBJoTzXvTG8aIbmsQUvTcdkQprnsWd0KYIZfoqtT30PwdyvEpBYbDcyzduDXqCgRlApecZlRdkJN8DEGGNQh2EWHY4bU5lpNanOtNteKVCq7zqEX5_5rt0D_J_JbbgZengEds-EhaGds_MtJLkjdNJl7c-Ig27i3EFQ0FlwWaQOYpHpv_7_H23_iZrZuu-lPOEKc_Bpc9qyoijmjvmxfsT0FZdksbVv-C2GcsKY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1041143536</pqid></control><display><type>article</type><title>Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Abdelmegeed, Mohamed A ; Banerjee, Atrayee ; Yoo, Seong-Ho ; Jang, Sehwan ; Gonzalez, Frank J ; Song, Byoung-Joon</creator><creatorcontrib>Abdelmegeed, Mohamed A ; Banerjee, Atrayee ; Yoo, Seong-Ho ; Jang, Sehwan ; Gonzalez, Frank J ; Song, Byoung-Joon</creatorcontrib><description>Background & Aims Ethanol-inducible cytochrome P450 2E1 (CYP2E1) activity contributes to oxidative stress. However, CYP2E1 may have an important role in the pathogenesis of high-fat mediated non-alcoholic steatohepatitis (NASH). Thus, the role of CYP2E1 in high-fat mediated NASH development was evaluated. Methods Male wild type (WT) and Cyp2e1 -null mice were fed a low-fat diet (LFD, 10% energy-derived) or a high-fat diet (HFD, 60% energy-derived) for 10 weeks. Liver histology and tissue homogenates were examined for various parameters of oxidative stress and inflammation. Results Liver histology showed that only WT mice fed a HFD developed NASH despite the presence of increased steatosis in both WT and Cyp2e1 -null mice fed HFD. Markers of oxidative stress such as elevated CYP2E1 activity and protein amounts, lipid peroxidation, protein carbonylation, nitration, and glycation with increased phospho-JNK were all markedly elevated only in the livers of HFD-fed WT mice. Furthermore, while the levels of inflammation markers osteopontin and F4/80 were higher in HFD-fed WT mice, TNFα and MCP-1 levels were lower compared to the corresponding LFD-fed WT. Finally, only HFD-fed WT mice exhibited increased insulin resistance and impaired glucose tolerance. Conclusions These data suggest that CYP2E1 is critically important in NASH development by promoting oxidative/nitrosative stress, protein modifications, inflammation, and insulin resistance.</description><identifier>ISSN: 0168-8278</identifier><identifier>EISSN: 1600-0641</identifier><identifier>DOI: 10.1016/j.jhep.2012.05.019</identifier><identifier>PMID: 22668639</identifier><identifier>CODEN: JOHEEC</identifier><language>eng</language><publisher>Kidlington: Elsevier B.V</publisher><subject>Animals ; Antigens, Differentiation - metabolism ; Biological and medical sciences ; Body Weight ; Chemokine CCL2 - metabolism ; CYP2E1 ; Cytochrome P-450 CYP2E1 - genetics ; Cytochrome P-450 CYP2E1 - metabolism ; Diet, High-Fat - adverse effects ; Fatty Liver - etiology ; Fatty Liver - metabolism ; Fatty Liver - pathology ; Gastroenterology and Hepatology ; Gastroenterology. Liver. Pancreas. Abdomen ; Glucose Tolerance Test ; Glycation End Products, Advanced - metabolism ; High-fat diet ; Inflammation ; Inflammation - complications ; Inflammation - metabolism ; Insulin Resistance ; JNK Mitogen-Activated Protein Kinases - metabolism ; Lipid Peroxidation ; Liver ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Mice ; Mice, Knockout ; NAFLD ; NASH ; Non-alcoholic Fatty Liver Disease ; Null mice ; Osteopontin - metabolism ; Other diseases. Semiology ; Oxidative Stress ; Phosphorylation ; Protein Carbonylation ; Protein modifications ; Receptor for Advanced Glycation End Products ; Receptors, Immunologic - metabolism ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Journal of hepatology, 2012-10, Vol.57 (4), p.860-866</ispartof><rights>2012</rights><rights>2015 INIST-CNRS</rights><rights>Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c551t-baf70aa48004bde7f1f918b6446e1d1a3bcdc846367ea6cb36802a36d2794e2c3</citedby><cites>FETCH-LOGICAL-c551t-baf70aa48004bde7f1f918b6446e1d1a3bcdc846367ea6cb36802a36d2794e2c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jhep.2012.05.019$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26340788$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22668639$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abdelmegeed, Mohamed A</creatorcontrib><creatorcontrib>Banerjee, Atrayee</creatorcontrib><creatorcontrib>Yoo, Seong-Ho</creatorcontrib><creatorcontrib>Jang, Sehwan</creatorcontrib><creatorcontrib>Gonzalez, Frank J</creatorcontrib><creatorcontrib>Song, Byoung-Joon</creatorcontrib><title>Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis</title><title>Journal of hepatology</title><addtitle>J Hepatol</addtitle><description>Background & Aims Ethanol-inducible cytochrome P450 2E1 (CYP2E1) activity contributes to oxidative stress. However, CYP2E1 may have an important role in the pathogenesis of high-fat mediated non-alcoholic steatohepatitis (NASH). Thus, the role of CYP2E1 in high-fat mediated NASH development was evaluated. Methods Male wild type (WT) and Cyp2e1 -null mice were fed a low-fat diet (LFD, 10% energy-derived) or a high-fat diet (HFD, 60% energy-derived) for 10 weeks. Liver histology and tissue homogenates were examined for various parameters of oxidative stress and inflammation. Results Liver histology showed that only WT mice fed a HFD developed NASH despite the presence of increased steatosis in both WT and Cyp2e1 -null mice fed HFD. Markers of oxidative stress such as elevated CYP2E1 activity and protein amounts, lipid peroxidation, protein carbonylation, nitration, and glycation with increased phospho-JNK were all markedly elevated only in the livers of HFD-fed WT mice. Furthermore, while the levels of inflammation markers osteopontin and F4/80 were higher in HFD-fed WT mice, TNFα and MCP-1 levels were lower compared to the corresponding LFD-fed WT. Finally, only HFD-fed WT mice exhibited increased insulin resistance and impaired glucose tolerance. Conclusions These data suggest that CYP2E1 is critically important in NASH development by promoting oxidative/nitrosative stress, protein modifications, inflammation, and insulin resistance.</description><subject>Animals</subject><subject>Antigens, Differentiation - metabolism</subject><subject>Biological and medical sciences</subject><subject>Body Weight</subject><subject>Chemokine CCL2 - metabolism</subject><subject>CYP2E1</subject><subject>Cytochrome P-450 CYP2E1 - genetics</subject><subject>Cytochrome P-450 CYP2E1 - metabolism</subject><subject>Diet, High-Fat - adverse effects</subject><subject>Fatty Liver - etiology</subject><subject>Fatty Liver - metabolism</subject><subject>Fatty Liver - pathology</subject><subject>Gastroenterology and Hepatology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Glucose Tolerance Test</subject><subject>Glycation End Products, Advanced - metabolism</subject><subject>High-fat diet</subject><subject>Inflammation</subject><subject>Inflammation - complications</subject><subject>Inflammation - metabolism</subject><subject>Insulin Resistance</subject><subject>JNK Mitogen-Activated Protein Kinases - metabolism</subject><subject>Lipid Peroxidation</subject><subject>Liver</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>NAFLD</subject><subject>NASH</subject><subject>Non-alcoholic Fatty Liver Disease</subject><subject>Null mice</subject><subject>Osteopontin - metabolism</subject><subject>Other diseases. Semiology</subject><subject>Oxidative Stress</subject><subject>Phosphorylation</subject><subject>Protein Carbonylation</subject><subject>Protein modifications</subject><subject>Receptor for Advanced Glycation End Products</subject><subject>Receptors, Immunologic - metabolism</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0168-8278</issn><issn>1600-0641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kk2L1TAUhoMoznX0D7iQbIRx0Zqvpi2IIJfxAwYcUBeuQpqe2tQ2uZOkA_ffm3KvCi5cnc3znnN4zkHoOSUlJVS-nspphEPJCGUlqUpC2wdoRyUhBZGCPkS7DDVFw-rmAj2JcSKEcNKKx-iCMSkbydsdCvtgkzV6xsHPgP2AzTF5Mwa_AL4VFcHsmuKr_ffbXF9h63AaAfdwD7M_LODSFhntjxEPOhXW9auBHjvvCj0bP_rZGhwT6OTzqjrlWfEpejToOcKzc71E395ff91_LG4-f_i0f3dTmKqiqej0UBOtRUOI6HqoBzq0tOmkEBJoTzXvTG8aIbmsQUvTcdkQprnsWd0KYIZfoqtT30PwdyvEpBYbDcyzduDXqCgRlApecZlRdkJN8DEGGNQh2EWHY4bU5lpNanOtNteKVCq7zqEX5_5rt0D_J_JbbgZengEds-EhaGds_MtJLkjdNJl7c-Ig27i3EFQ0FlwWaQOYpHpv_7_H23_iZrZuu-lPOEKc_Bpc9qyoijmjvmxfsT0FZdksbVv-C2GcsKY</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>Abdelmegeed, Mohamed A</creator><creator>Banerjee, Atrayee</creator><creator>Yoo, Seong-Ho</creator><creator>Jang, Sehwan</creator><creator>Gonzalez, Frank J</creator><creator>Song, Byoung-Joon</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121001</creationdate><title>Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis</title><author>Abdelmegeed, Mohamed A ; Banerjee, Atrayee ; Yoo, Seong-Ho ; Jang, Sehwan ; Gonzalez, Frank J ; Song, Byoung-Joon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c551t-baf70aa48004bde7f1f918b6446e1d1a3bcdc846367ea6cb36802a36d2794e2c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Antigens, Differentiation - metabolism</topic><topic>Biological and medical sciences</topic><topic>Body Weight</topic><topic>Chemokine CCL2 - metabolism</topic><topic>CYP2E1</topic><topic>Cytochrome P-450 CYP2E1 - genetics</topic><topic>Cytochrome P-450 CYP2E1 - metabolism</topic><topic>Diet, High-Fat - adverse effects</topic><topic>Fatty Liver - etiology</topic><topic>Fatty Liver - metabolism</topic><topic>Fatty Liver - pathology</topic><topic>Gastroenterology and Hepatology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Glucose Tolerance Test</topic><topic>Glycation End Products, Advanced - metabolism</topic><topic>High-fat diet</topic><topic>Inflammation</topic><topic>Inflammation - complications</topic><topic>Inflammation - metabolism</topic><topic>Insulin Resistance</topic><topic>JNK Mitogen-Activated Protein Kinases - metabolism</topic><topic>Lipid Peroxidation</topic><topic>Liver</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>NAFLD</topic><topic>NASH</topic><topic>Non-alcoholic Fatty Liver Disease</topic><topic>Null mice</topic><topic>Osteopontin - metabolism</topic><topic>Other diseases. Semiology</topic><topic>Oxidative Stress</topic><topic>Phosphorylation</topic><topic>Protein Carbonylation</topic><topic>Protein modifications</topic><topic>Receptor for Advanced Glycation End Products</topic><topic>Receptors, Immunologic - metabolism</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdelmegeed, Mohamed A</creatorcontrib><creatorcontrib>Banerjee, Atrayee</creatorcontrib><creatorcontrib>Yoo, Seong-Ho</creatorcontrib><creatorcontrib>Jang, Sehwan</creatorcontrib><creatorcontrib>Gonzalez, Frank J</creatorcontrib><creatorcontrib>Song, Byoung-Joon</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdelmegeed, Mohamed A</au><au>Banerjee, Atrayee</au><au>Yoo, Seong-Ho</au><au>Jang, Sehwan</au><au>Gonzalez, Frank J</au><au>Song, Byoung-Joon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis</atitle><jtitle>Journal of hepatology</jtitle><addtitle>J Hepatol</addtitle><date>2012-10-01</date><risdate>2012</risdate><volume>57</volume><issue>4</issue><spage>860</spage><epage>866</epage><pages>860-866</pages><issn>0168-8278</issn><eissn>1600-0641</eissn><coden>JOHEEC</coden><abstract>Background & Aims Ethanol-inducible cytochrome P450 2E1 (CYP2E1) activity contributes to oxidative stress. However, CYP2E1 may have an important role in the pathogenesis of high-fat mediated non-alcoholic steatohepatitis (NASH). Thus, the role of CYP2E1 in high-fat mediated NASH development was evaluated. Methods Male wild type (WT) and Cyp2e1 -null mice were fed a low-fat diet (LFD, 10% energy-derived) or a high-fat diet (HFD, 60% energy-derived) for 10 weeks. Liver histology and tissue homogenates were examined for various parameters of oxidative stress and inflammation. Results Liver histology showed that only WT mice fed a HFD developed NASH despite the presence of increased steatosis in both WT and Cyp2e1 -null mice fed HFD. Markers of oxidative stress such as elevated CYP2E1 activity and protein amounts, lipid peroxidation, protein carbonylation, nitration, and glycation with increased phospho-JNK were all markedly elevated only in the livers of HFD-fed WT mice. Furthermore, while the levels of inflammation markers osteopontin and F4/80 were higher in HFD-fed WT mice, TNFα and MCP-1 levels were lower compared to the corresponding LFD-fed WT. Finally, only HFD-fed WT mice exhibited increased insulin resistance and impaired glucose tolerance. Conclusions These data suggest that CYP2E1 is critically important in NASH development by promoting oxidative/nitrosative stress, protein modifications, inflammation, and insulin resistance.</abstract><cop>Kidlington</cop><pub>Elsevier B.V</pub><pmid>22668639</pmid><doi>10.1016/j.jhep.2012.05.019</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0168-8278 |
ispartof | Journal of hepatology, 2012-10, Vol.57 (4), p.860-866 |
issn | 0168-8278 1600-0641 |
language | eng |
recordid | cdi_proquest_miscellaneous_1041143536 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Animals Antigens, Differentiation - metabolism Biological and medical sciences Body Weight Chemokine CCL2 - metabolism CYP2E1 Cytochrome P-450 CYP2E1 - genetics Cytochrome P-450 CYP2E1 - metabolism Diet, High-Fat - adverse effects Fatty Liver - etiology Fatty Liver - metabolism Fatty Liver - pathology Gastroenterology and Hepatology Gastroenterology. Liver. Pancreas. Abdomen Glucose Tolerance Test Glycation End Products, Advanced - metabolism High-fat diet Inflammation Inflammation - complications Inflammation - metabolism Insulin Resistance JNK Mitogen-Activated Protein Kinases - metabolism Lipid Peroxidation Liver Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Mice Mice, Knockout NAFLD NASH Non-alcoholic Fatty Liver Disease Null mice Osteopontin - metabolism Other diseases. Semiology Oxidative Stress Phosphorylation Protein Carbonylation Protein modifications Receptor for Advanced Glycation End Products Receptors, Immunologic - metabolism Tumor Necrosis Factor-alpha - metabolism |
title | Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A59%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Critical%20role%20of%20cytochrome%20P450%202E1%20(CYP2E1)%20in%20the%20development%20of%20high%20fat-induced%20non-alcoholic%20steatohepatitis&rft.jtitle=Journal%20of%20hepatology&rft.au=Abdelmegeed,%20Mohamed%20A&rft.date=2012-10-01&rft.volume=57&rft.issue=4&rft.spage=860&rft.epage=866&rft.pages=860-866&rft.issn=0168-8278&rft.eissn=1600-0641&rft.coden=JOHEEC&rft_id=info:doi/10.1016/j.jhep.2012.05.019&rft_dat=%3Cproquest_cross%3E1041143536%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1041143536&rft_id=info:pmid/22668639&rft_els_id=S0168827812004199&rfr_iscdi=true |